A recent report indicates that promoting liver-specific UCP expression reverses hypertriglyceridemia, NAFLD and insulin resistance, indicating that UCPs play a crucial role in glucose and FA metabolism38. The gene discussed is UCP1; the disease is metabolic dysfunction-associated steatotic liver disease.